We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TRV:NYSEThe Travelers Companies, Inc. Analysis

Data as of 2026-05-26 - not real-time

$304.84

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Travelers is trading just above its 20‑day SMA with a bullish MACD histogram and a clear support level near $291, suggesting short‑term price resilience. Technical momentum is reinforced by an increasing volume trend and a modest upside potential of roughly 3% based on current resistance. Fundamentally, the stock’s PE ratio sits well below the industry average, while ROE exceeds 25% and free cash flow remains robust, supporting a strong dividend payout at a 13% payout ratio. The balance sheet shows manageable debt levels and ample cash, indicating the dividend is sustainable. Recent launch of an AI‑driven claim insights platform could enhance underwriting efficiency and margin stability. Analyst consensus tilts toward a “hold” stance, yet the DCF fair value of about $841 implies the market is significantly undervaluing the company. Combined, the technical bullishness and deep valuation gap make Travelers an attractive opportunity for investors seeking value with defensive characteristics.
Given the low beta and moderate volatility, the stock presents a relatively low‑risk profile within the cyclical insurance sector, while regulatory and geographic exposures remain limited. The modest revenue growth is offset by high profitability and attractive yield, positioning Travelers as a solid candidate for medium‑ to long‑term accumulation.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (MACD, SMA alignment)
  • Support level holding with increasing volume
  • Upside potential relative to resistance

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued price versus DCF and peers
  • Strong cash flow and sustainable dividend
  • Cyclical nature of P&C insurance limiting rapid upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Deep valuation gap (DCF fair value far above market)
  • High ROE and low payout ratio indicating dividend durability
  • Strategic AI initiative that may boost margins over time

Key Metrics & Analysis

Financial Health

Revenue Growth1.00%
Profit Margin15.54%
P/E Ratio9.1
ROE25.27%
ROA4.44%
Debt/Equity28.98
P/B Ratio2.0
Op. Cash Flow$11.4B
Free Cash Flow$13.3B
Industry P/E16.7

Technical Analysis

TrendBullish
RSI55.0
Support$291.83
Resistance$311.58
MA 20$302.45
MA 50$299.73
MA 200$287.19
MACDBullish
VolumeIncreasing
Fear & Greed Index91.05

Valuation

Fair Value$841.50
Target Price$313.74
Upside/Downside2.92%
GradeUndervalued
TypeValue
Dividend Yield1.63%

Risk Assessment

Beta0.20
Volatility15.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.